Literature DB >> 15911059

Criteria and procedures for determining benefit packages in health care. A comparative perspective.

Stefan Gress1, Dea Niebuhr, Heinz Rothgang, Jürgen Wasem.   

Abstract

The legitimacy of procedures and criteria for determining benefit packages depends crucially on the representation of stakeholders in decision-making bodies, the transparency of procedures and the consistency of benefit decisions. Moreover, the assessment of the costs of healthcare services and its application as a decision criterion can be an important policy instrument in order to increase the overall efficiency of healthcare systems. Our analysis of procedures and criteria for determining benefit packages in England, Germany and Switzerland established potential for developing more legitimate procedures and criteria for benefits decisions. In Germany, representation of stakeholders and transparency of procedures can be improved. Consistency of decision-making is hindered by the veto positions of selected stakeholders. Moreover, benefit decisions are made for different healthcare sectors separately. In Switzerland, transparency of procedures is virtually non-existent at the moment. Thus, it is impossible to assess the consistency of decision-making. Only in England the costs of healthcare services influence the decision to include or exclude them.

Keywords:  Health Care and Public Health

Mesh:

Year:  2004        PMID: 15911059     DOI: 10.1016/j.healthpol.2004.10.005

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  5 in total

1.  Role of centralized review processes for making reimbursement decisions on new health technologies in Europe.

Authors:  Tania Stafinski; Devidas Menon; Caroline Davis; Christopher McCabe
Journal:  Clinicoecon Outcomes Res       Date:  2011-08-30

2.  The Relationship Between the Scope of Essential Health Benefits and Statutory Financing: An International Comparison Across Eight European Countries.

Authors:  Philip J van der Wees; Joost J G Wammes; Gert P Westert; Patrick P T Jeurissen
Journal:  Int J Health Policy Manag       Date:  2015-09-12

3.  Reform of prescription drug reimbursement and pricing in the German social health insurance market: a comparison of three scenarios.

Authors:  Stefan Gress; Dea Niebuhr; Uwe May; Jürgen Wasem
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

4.  Analysing coverage decision-making: opening Pandora's box?

Authors:  Katharina Elisabeth Fischer; Reiner Leidl
Journal:  Eur J Health Econ       Date:  2014-02-06

5.  Scoping literature review on the basic health benefit package and its determinant criteria.

Authors:  Ramin Hayati; Peivand Bastani; Mohammad Javad Kabir; Zahra Kavosi; Ghasem Sobhani
Journal:  Global Health       Date:  2018-03-02       Impact factor: 4.185

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.